Osteopontin in post-subarachnoid hemorrhage pathologies

Area of Science:

• Neuroscience
• Biochemistry
• Pathology

Background:

• Subarachnoid hemorrhage (SAH) from ruptured intracranial aneurysms presents significant treatment challenges.
• Post-SAH complications include early brain injury, delayed cerebral ischemia, and chronic hydrocephalus.
• Osteopontin (OPN), a matricellular protein, exhibits context-dependent beneficial or harmful effects.

Purpose of the Study:

• To review the multifaceted roles of Osteopontin (OPN) in the pathological processes following aneurysmal subarachnoid hemorrhage (SAH).
• To elucidate the dualistic functions of OPN, highlighting its neuroprotective and detrimental impacts in the post-SAH context.

Main Methods:

• Literature review of studies investigating Osteopontin (OPN) in the context of aneurysmal subarachnoid hemorrhage (SAH).
• Analysis of OPN's molecular functions, including its isoforms and post-translational modifications.
• Examination of OPN's effects on neuronal apoptosis, blood-brain barrier integrity, and cerebrovascular tone.

Main Results:

• OPN demonstrates neuroprotective effects against early brain injury and delayed cerebral ischemia post-SAH.
• These beneficial effects are mediated by suppressing neuronal apoptosis, maintaining blood-brain barrier integrity, and preventing cerebrovascular constriction.
• Conversely, excessive and prolonged OPN secretion is associated with the development of chronic hydrocephalus, necessitating surgical intervention.

Conclusions:

• Osteopontin (OPN) exhibits a complex, context-dependent role in the pathophysiology of aneurysmal subarachnoid hemorrhage (SAH).
• Targeting OPN may offer therapeutic potential for mitigating early brain injury and ischemia, but careful consideration of its role in hydrocephalus is crucial.
• Further research is warranted to fully understand and harness OPN's therapeutic implications in SAH management.